Connolly, Stuart J., Wallentin, Lars, Ezekowitz, Michael D., Eikelboom, John, Oldgren, Jonas, Reilly, Paul A., Brueckmann, Martina, Pogue, Janice, Alings, Marco, Amerena, John V., Avezum, Alvaro, Baumgartner, Iris, Budaj, Andrzej J., Chen, Jyh-Hong, Dans, Antonio L., Darius, Harald, Di Pasquale, Giuseppe, Ferreira, Jorge, Flaker, Greg C., Flather, Marcus D., Franzosi, Maria Grazia, Golitsyn, Sergey P., Halon, David A., Heidbuchel, Hein, Hohnloser, Stefan H., Huber, Kurt, Jansky, Petr, Kamensky, Gabriel, Keltai, Matyas, Kim, Sung Soon, Lau, Chu-Pak, Le Heuzey, Jean-Yves, Lewis, Basil S., Liu, Lisheng, Nanas, John, Omar, Razali, Pais, Prem, Pedersen, Knud E., Piegas, Leopoldo S., Raev, Dimitar, Smith, Pal J., Talajic, Mario, Tan, Ru San, Tanomsup, Supachai, Toivonen, Lauri, Vinereanu, Dragos, Xavier, Denis, Zhu, Jun, Wang, Susan Q., Duffy, Christine O., Themeles, Ellison and Yusuf, Salim (2013) The long-term multicenter observational study of dabigatran treatment in patients with atrial fibrillation (RELY-ABLE) Study. Circulation, 128 (3). pp. 237-243.
Full text not available from this repository. (Request a copy)Abstract
During follow-up of between 1 and 3 years in the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial, 2 doses of dabigatran etexilate were shown to be effective and safe for the prevention of stroke or systemic embolism in patients with atrial fibrillation. There is a need for longer-term follow-up of patients on dabigatran and for further data comparing the 2 dabigatran doses.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | dose-response relationship, drug,humans,stroke,aged,hemorrhage,beta-alanine,antithrombins,benzimidazoles,hospitalization,aged, 80 and over,embolism,treatment outcome,middle aged,follow-up studies,atrial fibrillation,female,male |
Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023) Faculty of Medicine and Health Sciences > Research Groups > Norwich Clinical Trials Unit Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health |
Depositing User: | Pure Connector |
Date Deposited: | 11 Nov 2013 13:20 |
Last Modified: | 19 Oct 2023 01:11 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/44355 |
DOI: | 10.1161/CIRCULATIONAHA.112.001139 |
Actions (login required)
View Item |